*By: Madison Alworth*
It's summer, which means it's rosé season. The pink drink is popping up everywhere from bars to Instagram feeds. And one company is trying to capitalize on the summertime favorite.
Bev launched in May with a brand new canned product catering to millennial women. It started as a passion project for CEO Alix Peabody.
"To get the first product I cashed out my 401K and bought a bunch of rosé," said Peabody, who was previously a financial recruiter.
Some might say it was more than "a bunch"ーPeabody bought 300 gallons of the pink stuff.
Still, Bev has plenty of competition. There's [Ruza Rosé](http://ruzawines.winc.com/), [Babe] (https://www.swishbev.com/products/babe-rose-with-bubbles-4-pack), and [Lila](http://www.lilawines.com/) just to name a few. Peabody has an idea about why there's so much interest.
"I think a lot of it has to do with millennial culture and people just being generally excited about accessibility and 'un-snobbery,' if you will," she said.
For full interview, [click here](https://cheddar.com/videos/bev-drink-your-rose-from-a-can).
Ben Geman, Energy Reporter at Axios, joins to discuss the latest Middle East tensions, Brent crude price swings, and why gas prices aren’t falling with oil.
Al Root, Associate Editor at Barron's, joins to discuss Tesla’s robotaxis going live in Texas—what it means for autonomy, safety, and the EV race ahead.
Dena Jalbert, M&A expert and CEO of Align Business Advisory Services, on the state of U.S. M&A: deals worth $1–$10 billion (including debt) are surging.
Jeremy Jansen, Head of Supply Chain at Wells Fargo, unpacks the ongoing trade talks between the United States and China as consumers still wonder about tariffs.
IBM Fellow Jerry Chow talks IBM’s expansion of the Quantum Data Center in Poughkeepsie, installing Heron processors that deliver utility‑scale performance.
Ken Shepard, Head of Specialty Asset Management at Bank of America, discusses the importance of real assets and unpacks the bank's specialty asset outlook.
Cardinal Health's Debbie Weitzman explains how the company's Advanced Therapy Solutions Innovation Center aims to improve access to specialty medicines. Watch!
